Skip to content

Common Stock at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
100M+249,900%
Viatris logo
ViatrisVTRS
3B
PTH
Pelthos Therapeutics Inc.PTHS
200M+32,206,019%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$18K0.0%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6K+20.0%
Opko Health logo
Opko HealthOPK
$7.85M+11.9%

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.4%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's common stock?
Scilex Holding Company (SCLX) reported common stock of $1K in Q1 2026.
How has Scilex Holding Company's common stock changed year-over-year?
Scilex Holding Company's common stock decreased by 0.0% year-over-year, from $1K to $1K.
What is the long-term trend for Scilex Holding Company's common stock?
Over 5 years (2020 to 2025), Scilex Holding Company's common stock has grown at a -91.3% compound annual growth rate (CAGR), from $200M to $1K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).